Interv Akut Kardiol. 2014;13(3):127-130

Self-expandable coronary stents

David Horák, Vladimír Hraboš, Zdeněk Šembera, Lukáš Jaworski
Kardiocentrum Krajská nemocnice Liberec a.s.

In the last decade we witness reinvention of self-expandable coronary stents. Today’s generation of these devices is made predominantly

from nitinol giving them specific properties different from stainless steel baloon-expandable stents. Some of those devices were

developed for dedicated use e.g. bifurcation lesions or very small vessels. We still do not have enough clinical data supporting use of

self-expandable stents in wider extent.

Keywords: selfexpandible stent, nitinol, baloon-expandable stent, bifurcation, acute coronary syndrom

Published: October 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horák D, Hraboš V, Šembera Z, Jaworski L. Self-expandable coronary stents. Interv Akut Kardiol. 2014;13(3):127-130.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987; 316(12): 701-706. Go to original source... Go to PubMed...
    2. Kume T, Waseda K, Koo BK, et al. Intravascular ultrasound analysis of small vessel lesions treated with the sparrow coronary stent system: Results of the CARE II trial. Catheter Cardiovasc Interv. 2014; 83(1): 19-24. Go to original source... Go to PubMed...
    3. http://en.wikipedia.org/wiki/Nickel_titanium.
    4. http://en.wikipedia.org/wiki/Nitinol_biocompatibility.
    5. Amoroso G, van Geuns RJ, Spaulding C, et al. Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: Results from the APPOSITION I study. EuroIntervention. 2011; 7(4): 428-436. Go to original source... Go to PubMed...
    6. van Geuns RJ, Tamburino C, Fajadet J, et al. Self-expanding versus balloon-expandable stents in acute myocardial infarction: Results from the APPOSITION II study: Self-expanding stents in ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2012; 5(12): 1209-1219. Go to original source... Go to PubMed...
    7. 1348482997_ APPOSITIONIIIResults_ST-APIII-120611.pdf. http://www.stentys.com/file_bdd/annexes/1348482997_APPOSITIONIIIResults_ST-APIII-120611.pdf.
    8. APPOSITION IV: Self-expanding SES covers struts better, faster than balloon-expandable DES - EuroPCR 2014 - TCTMD.
    9. Verheye S, Ramcharitar S, Grube E, et al. Six-month clinical and angiographic results of the STENTYS (R) self-apposing stent in bifurcation lesions. EuroIntervention. 2011; 7(5): 580-587. Go to original source... Go to PubMed...
    10. Naber C, Nef H, Külekçi K, et al. TCT-22 the STENTYS self-expanding drug-eluting stent in coronary bifurcation lesions at 6 months follow-up: Results from the OPEN II trial. J Am Coll Cardiol. 2013; 62(18): B8-B9. Go to original source...
    11. The DIVERGE trial (drug eluting stent intervention for treating side branches effectively): 3-year clinical results. http://www.pcronline.com/eurointervention/N_issue/285/.
    12. Verheye S, Agostoni P, Dubois CL, et al. 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: The DIVERGE (drug-eluting stent intervention for treating side branches effectively) study. J Am Coll Cardiol. 2009; 53(12): 1031-1039. Go to original source... Go to PubMed...
    13. Fath-Ordoubadi F, Hauptmann K, Latib A, et al. TCT-690 safety and clinical efficacy of sideguard(R) stent for treatment of bifurcation lesions: Interim results from the european sideguard(R) bifurcation registry study. J Am Coll Cardiol. 2012; 60(17): B201. Go to original source...
    14. Latib A, Chieffo A. The cappella sideguard stent. EuroIntervention. 2010; 6(Suppl J): J143-146. Go to original source... Go to PubMed...
    15. Mamas MA, Farooq V, Latib A, et al. Use of the sideguard (cappella) stent in bifurcation lesions: A real-world experience. EuroIntervention. 2012; 7(10): 1170-1180. Go to original source... Go to PubMed...
    16. Kobayashi Y, Honda Y, Christie LG, et al. Long-term vessel response to a self-expanding coronary stent: A serial volumetric intravascular ultrasound analysis from the ASSURE trial. J Am Coll Cardiol. 2001;37 (5): 1329 <last_page> 1334. Go to original source... Go to PubMed...
    17. Wykrzykowska JJ, Diletti R, Gutierrez-Chico JL, et al. Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: Report of the pilot study vShield evaluated at cardiac hospital in rotterdam for investigation and treatment of TCFA (SECRITT). EuroIntervention. 2012; 8(8): 945-954. Go to original source... Go to PubMed...
    18. Shin ES, Garcia-Garcia HM, Okamura T, et al. Comparison of acute vessel wall injury after self-expanding stent and conventional balloon-expandable stent implantation: A study with optical coherence tomography. J Invasive Cardiol. 2010; 22(9): 435-439. Go to PubMed...
    19. TCT-222: Intravascular ultrasound analysis of small coronary lesions treated with the CardioMind coronary stent system: IVUS results of the CARE II trial. J Am Coll Cardiol. 2010; 56(13): B51-B52.
    20. Capodanno D, Dipasqua F, Tamburino C. Novel drug-eluting stents in the treatment of de novo coronary lesions. Vasc Health Risk Manag. 2011; 7: 103-118. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.